05/17/2020
Bio-Rad Laboratories Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.
05/06/2020
Out of the Blue CRISPR and Genotyping Extension kits awarded “Best New Technology Innovation for Science” and the Science of Opioid Dependence Kit won in the category of “Best Tried & True Technology Teaching and
05/06/2020
The latest imaging system from Bio-Rad’s GelDoc product line, offers sensitivity, performance, and reliability in a compact system.
02/03/2020
Bio-Rad’s ZE5 Cell Analyzer now comes with FCS Express flow cytometry analysis software from De Novo Software.
01/20/2020
During a Bio-Rad workshop, speakers will discuss how following next-generation sequencing with Droplet Digital PCR for routine serial monitoring is effective in detecting residual disease or molecular relapse.
01/09/2020
The novel technology provides a holistic view of the complete transcriptome and overcomes limitations of other available kits.
12/06/2019
Scientists will present more than 40 abstracts that used Bio-Rad’s droplet-based technologies to advance research into both malignant and non-malignant blood disorders.
12/05/2019
More than two dozen scientists at the AMP 2019 Annual Meeting and Expo presented research featuring Droplet Digital PCR (ddPCR). Included were studies validating ddPCR Assays for predicting and monitoring treatment
11/10/2019
EveryBlot Blocking Buffer, a western blot blocking reagent that offers 5-minute blocking time and produces higher signal to lower background levels resulting in greater sensitivity for all detection methods.
11/07/2019
Bio-Rad will demonstrate the new QX ONE platform to a select group of customers as part of early-access launch.